Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine ...

The retrospective cohort study included more than 130,000 people in the US. It reveals that the shingles vaccine (called ...

The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster ...

This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for ...

A recent study suggests that certain immunizations may unexpectedly protect against cognitive decline, potentially reducing ...

The Food and Drug Administration (FDA) has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

Shingrix has been administered in a two-step process. It involved combining two separate vials—a freeze-dried (lyophilized) powder containing the antigen, and a liquid adjuvant, by trained healthcare ...

Shingrix's manufacturer, GlaxoSmithKline, didn't anticipate it would be so popular when it first hit the market. In the first six months of 2018 alone, more doses of Shingrix were administered in ...

Shingrix is also better than Zostavax in preventing nerve pain that continues after a shingles rash has cleared -- about 90 percent effective versus 65 percent effective, the briefing stated.

The US Food and Drug Administration (FDA) has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a ...

The newly approved prefilled syringe version of Shingrix is expected to simplify administration and supports efforts to ...